Get started
Author

Elisabetta Biasini

Observed names: Biasini, E., Biasini, Elisabetta, E. Biasini
ORCID: 0000-0002-6764-4703
Observed ORCID: 0000-0002-6764-4703
OpenAlex ID: A5001054792
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
2009 · Paola Fisicaro, Caterina Valdatta, et al. · Gastroenterology · 488
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
2016 · Fabio Farinati, Alessandro Vitale, et al. · PLoS Medicine · 142
PDF
Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma
2002 · Eugenio Caturelli, Francesca Bartolucci, et al. · The American Journal of Gastroenterology · 70
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
2016 · Anna Pecorelli, Barbara Lenzi, et al. · Liver International · 64
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments
2016 · Elisabetta Cariani, Massimo Pilli, et al. · OncoImmunology · 48
PDF
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma
2024 · Alessandro Vitale, Pierluigi Romano, et al. · JAMA Surgery · 47
Diagnosis of Hepatocellular Carcinoma Complicating Liver Cirrhosis: Utility of Repeat Ultrasound-Guided Biopsy after Unsuccessful First Sampling
2002 · Eugenio Caturelli, Elisabetta Biasini, et al. · CardioVascular and Interventional Radiology · 43
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
2021 · Alessandra Zecca, Valeria Barili, et al. · Cells · 39
PDF
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison.
2022 · Simone Famularo, Matteo Donadon, et al. · PubMed · 26
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting
2021 · Maria Corina Plaz Torres, Quirino Lai, et al. · Journal of Clinical Medicine · 23
PDF
Percutaneous Ultrasound-Guided Radiofrequency Ablation of an Allograft Renal Cell Carcinoma: A Case Report
2011 · A. Olivani, M. Iaria, et al. · Transplantation Proceedings · 19
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
2022 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 16
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
2023 · Nicola Reggidori, Laura Bucci, et al. · JHEP Reports · 15
PDF
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
2021 · Claudia Campani, Alessandro Vitale, et al. · Liver Cancer · 15
PDF
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma
2022 · Edoardo G. Giannini, Giulia Pieri, et al. · Digestive and Liver Disease · 12
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment
2021 · Alessandro Cucchetti, Annagiulia Gramenzi, et al. · European Journal of Cancer · 12
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics
2021 · Mario Silva, Michele Maddalo, et al. · Abdominal Radiology · 12
PDF
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
2021 · Giovanni Marasco, Francesco Poggioli, et al. · Cancers · 12
PDF
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
2021 · Giovanni Marasco, Antonio Colecchia, et al. · Digestive and Liver Disease · 11
Metabolic disorders across hepatocellular carcinoma in Italy
2018 · Filomena Morisco, Maria Guarino, et al. · Liver International · 10
PDF
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma
2024 · Edoardo G. Giannini, Andrea Pasta, et al. · Liver International · 8
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care
2024 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 8
PDF
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer
2022 · Alessandra Zecca, Valeria Barili, et al. · Frontiers in Immunology · 8
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison
2025 · Felice Giuliante, Simone Famularo, et al. · JHEP Reports · 6
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs
2021 · Brian I. Carr, Vito Guerra, et al. · Cancers · 5
PDF
Works count: 43
Citation count: 1,167
H-index: 14
I10-index: 20
Year
Topic
Type